BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17665855)

  • 1. Influence of the type of cellulose on properties of multi-unit target releasing in stomach dosage form with verapamil hydrochloride.
    Sawicki W; Łunio R; Walentynowicz O; Kubasik-Juraniec J
    Acta Pol Pharm; 2007; 64(1):81-8. PubMed ID: 17665855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compressibility of floating pellets with verapamil hydrochloride coated with dispersion Kollicoat SR 30 D.
    Sawicki W; Lunio R
    Eur J Pharm Biopharm; 2005 May; 60(1):153-8. PubMed ID: 15848067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compressibility of gastroretentive pellets coated with Eudragit NE using a single-stroke and a rotary tablet press.
    Łunio R; Sawicki W; Skoczeń P; Walentynowicz O; Kubasik-Juraniec J
    Pharm Dev Technol; 2008; 13(4):323-31. PubMed ID: 18649222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of microcrystalline cellulose and powder cellulose after extrusion/spheronization as studied by fourier transform Raman spectroscopy and environmental scanning electron microscopy.
    Fechner PM; Wartewig S; Füting M; Heilmann A; Neubert RH; Kleinebudde P
    AAPS PharmSci; 2003 Nov; 5(4):E31. PubMed ID: 15198519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the components of Kollicoat SR film on mechanical properties of floating pellets from the point of view of tableting.
    Lunio R; Sawicki W
    Pharmazie; 2008 Oct; 63(10):731-5. PubMed ID: 18972835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel multifunctional pharmaceutical excipients derived from microcrystalline cellulose-starch microparticulate composites prepared by compatibilized reactive polymer blending.
    Builders PF; Bonaventure AM; Tiwalade A; Okpako LC; Attama AA
    Int J Pharm; 2010 Mar; 388(1-2):159-67. PubMed ID: 20060448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.
    Ghanam D; Kleinebudde P
    Int J Pharm; 2011 May; 409(1-2):9-18. PubMed ID: 21335073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained release pellets based on poly(N-isopropyl acrylamide): matrix and in situ photopolymerization-coated systems.
    Mayo-Pedrosa M; Alvarez-Lorenzo C; Lacík I; Martinez-Pacheco R; Concheiro A
    J Pharm Sci; 2007 Jan; 96(1):93-105. PubMed ID: 16967440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Powdered cellulose as excipient for extrusion-spheronization pellets of a cohesive hydrophobic drug.
    Alvarez L; Concheiro A; Gómez-Amoza JL; Souto C; Martínez-Pacheco R
    Eur J Pharm Biopharm; 2003 May; 55(3):291-5. PubMed ID: 12754003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C; Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation of lipid bearing pellets as a delivery system for poorly soluble drugs.
    Chopra S; Venkatesan N; Betageri GV
    Int J Pharm; 2013 Mar; 446(1-2):136-44. PubMed ID: 23422274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the degree of polymerization on the behavior of cellulose during homogenization and extrusion/spheronization.
    Kleinebudde P; Jumaa M; El Saleh F
    AAPS PharmSci; 2000; 2(3):E21. PubMed ID: 11741237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization.
    Charoenthai N; Kleinebudde P; Puttipipatkhachorn S
    J Pharm Sci; 2007 Sep; 96(9):2469-84. PubMed ID: 17286294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct compression of cushion-layered ethyl cellulose-coated extended release pellets into rapidly disintegrating tablets without changes in the release profile.
    Hosseini A; Körber M; Bodmeier R
    Int J Pharm; 2013 Dec; 457(2):503-9. PubMed ID: 23892153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the porosity of cushioning excipients on the compaction of coated multi-particulates.
    Elsergany RN; Chan LW; Heng PWS
    Eur J Pharm Biopharm; 2020 Jul; 152():218-228. PubMed ID: 32445966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of floating pellets with verapamil hydrochloride.
    Sawicki W; Głód J
    Acta Pol Pharm; 2004; 61(3):185-90. PubMed ID: 15481243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation of sustained-release dosage form of verapamil hydrochloride by solid dispersion technique using Eudragit RLPO or Kollidon SR.
    Sahoo J; Murthy PN; Biswal S; Manik
    AAPS PharmSciTech; 2009; 10(1):27-33. PubMed ID: 19145487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of microcrystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization.
    Alvarez L; Concheiro A; Gómez-Amoza JL; Souto C; Martínez-Pacheco R
    Drug Dev Ind Pharm; 2002 Apr; 28(4):451-6. PubMed ID: 12056538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the tabletting behaviour of microcrystalline cellulose pellets by the incorporation of polyethylene glycol.
    Nicklasson F; Alderborn G
    Eur J Pharm Sci; 1999 Oct; 9(1):57-65. PubMed ID: 10493997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the effects of the physical characteristics of microcrystalline cellulose on performance in extrusion spheronization.
    Heng PW; Koo OM
    Pharm Res; 2001 Apr; 18(4):480-7. PubMed ID: 11451035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.